Texas Byetta/Januvia/Victoza Lawyer

September 19, 2013 @ 02:37 PM -- by

Byetta (exenatide synthetic), a GLP-1 receptor agonist, was approved by the FDA on April 28, 2005 for use by adults with Type 2 Diabetes. If you are a type-2 diabetic who got pancreatic cancer, thyroid cancer or pancreatitis after taking Byetta, Januvia, Victoza or other medications belonging to a class of drugs known as incretin mimetics, you should contact us for a free evaluation as to whether you have a potential lawsuit. 

 Byetta (exenatide synthetic), a GLP-1 receptor agonist, was approved by the FDA on April 28, 2005 for use by adults with Type 2 Diabetes. If you are a type-2 diabetic who got pancreatic cancer, thyroid cancer or pancreatitis after taking Byetta, Januvia, Victoza or other medications belonging to a class of drugs known as incretin mimetics, you should contact us for a free evaluation as to whether you have a potential lawsuit. 

These self-injectable medications stimulate the pancreas to produce insulin in persons with type-2 diabetes. They have been the subject of warnings by the U.S. Food and Drug Administration (FDA) since 2007. In fact, scientific studies have shown that certain types of drugs which affect the GLP-1 metabolic pathway , like Byetta, Janumet, Januvia and Victoza may increase the risk of both pancreatitis and pancreatic cancer. Various lawsuits have been filed against Amylin Pharmaceuticals, the maker of Byetta, since 2008.

In October 2007, the first U.S. FDA warning about the connection between Byetta and pancreatitis was issued after thirty users allegedly developed an acute form of pancreatitis. One year later, another alert was issued after the FDA received six more pancreatitis reports, which included two deaths.

In February 2011, links between Byetta and pancreatic cancer began to come together after a study published in Gastroenterology showed that users of the medication had a three times increased risk of the disease.

Moreover, in March 2013, the U.S. FDA alerted people that it would be investigating Byetta and other incretin mimetics like Januvia after hearing information from a study showing the drug’s potential to cause pancreatic duct metaplasia.

If you or a loved one took Byetta, Januvia, Victoza or other medications belonging to this class of drugs known as incretin mimetics and developed pancreatic cancer, thyroid cancer or pancreatitis, contact Texas diabetes drug lawyer Scott Nelson. Mr. Nelson serves all of Texas.